Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Adaptive Biotechnologies Announces Pricing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 27 Jun 2019
Related companies:  Adaptive Biotechnologies Corporation | Adaptive Biotechnologies (Diagnostics)

Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) Overview 2019: An Oral Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1), VEGFR-2, & VEGFR-3

DUBLIN, June 26, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

Global paroxysmal nocturnal hemoglobinuria (PNH) treatment market is expected to grow with a CAGR of 11.6% over the forecast period from 2019-2025

NEW YORK, June 26, 2019 /PRNewswire/ -- The report on the global paroxysmal nocturnal hemoglobinuria (PNH) treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

Global needle-free diabetes care market is expected to grow with a CAGR of 7.8% over the forecast period from 2019-2025

NEW YORK, June 26, 2019 /PRNewswire/ -- The report on the global needle-free diabetes care market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

Global metastatic breast cancer treatment market is expected to grow with a CAGR of 9.6% over the forecast period from 2019-2025

NEW YORK, June 26, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 Jun 2019

Global phenylketonuria treatment market is expected to grow with a healthy CAGR over the forecast period from 2019-2025

NEW YORK, June 26, 2019 /PRNewswire/ -- The report on the global phenylketonuria treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

Global smart inhalers market is expected to grow with a CAGR of 13.4% over the forecast period from 2019-2025

NEW YORK, June 26, 2019 /PRNewswire/ -- The report on the global smart inhalers market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

Global narcolepsy treatment market is expected to grow with a CAGR of 7.8% over the forecast period from 2019-2025

NEW YORK, June 26, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 Jun 2019

First TAVR Successfully Deployed at Henry Ford Allegiance Health

JACKSON, Mich., June 26, 2019 /PRNewswire/ -- Doctors performed the first catheter-based replacement of an aortic heart valve today at Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

Orenitram (treprostinil; United Therapeutics) Market Overview - Newer Brand Uptravi (selexipag; Johnson & Johnson/Nippon Shinyaku) Poses Tough Competition in the Oral Prostacyclin Class

DUBLIN, June 26, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

Kymriah (tisagenlecleucel; Novartis) Drug Profile 2019: A Cluster of Differentiation (CD)19-Targeted Genetically Modified Autologous T-cell Immunotherapy

DUBLIN, June 26, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited -

NEW ORLEANS, June 26, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 20, 2019 to file lead plaintiff applications in a securities class action lawsuit against... Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

The World Market for Maternity Apparel, 2019: Forecast to 2024 with Profiles on 59 Industry Players

DUBLIN, June 26, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019

Medicure Announces Results of 2019 Annual Meeting of Shareholders

WINNIPEG, June 26, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJD.PK), a pharmaceutical company, today announced the results of its annual meeting of shareholders which took place on June 26, 2019. All director nominees were re-appointed... Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019
Related companies:  Medicure Inc.

ESSA Provides an Update to the Acquisition of Realm Therapeutics

HOUSTON and VANCOUVER, June 26, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer provides an update, further to the announcement made on May 16, 2019 announcing... Read more ››

By: PR Newswire Association LLC. - 27 Jun 2019
Related companies:  ESSA Pharma Inc.

Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-502 Topical in Patients with Alopecia Areata Did Not Meet Endpoints

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Aclaris Therapeutics, Inc.

Verrica Pharmaceuticals Achieves Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with Common Warts

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Verrica Pharmaceuticals Inc.

VIVUS and Nordmark Amend Contract Manufacturing Agreement to Supply Current and Future Demand for PANCREAZE®

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Vivus, Inc.

Harvard Bioscience Subsidiary Data Sciences International Launches Hardware for Expanding Research Capabilities

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Harvard Bioscience, Inc.

Forward Pharma A/S Announces Intention to Transfer its U.S. Public Listing to the Nasdaq Capital Market Stock Exchange

Read more ››
By: Nasdaq / GlobenewsWire - 26 Jun 2019
Related companies:  Forward Pharma A/S
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑